Faten N. Aberra, MD, MSCE

faculty photo
Associate Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Division of Gastroenterology
748 Perelman Center for Advanced Medicine
South Pavilion
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-615-9073
Fax: 215-349-5915
BA (Biochemistry)
Swarthmore College, 1993.
Dartmouth Medical School, 1997.
University of Pennsylvania, 2004.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Blonski W, kundu R, Lewis J, Aberra F, Osterman M, and Lichtenstein GR.: Is dysplasia visible during surveillance colonoscopy in ulcerative colitis? Scandinavian Journal of Gastroenterology 43(6): 698-703, 2008.

Blonski W, Kundu R, Furth EF, Lewis J, Aberra F, and Lichtenstein GR: High-Grade Dysplastic Adenoma-Like Mass Lesions are not an Indication for Colectomy in Patients with Ulcerative Colitis. Scandinavian Journal of Gastroenterology 43(7): 817-820, 2008.

James D. Lewis, Shaokun Chuai, Lisa Nessel, Gary R. Lichtenstein, Faten N. Aberra, Jonas H. Ellenberg: Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis. Inflammatory Bowel Diseases 14(12): 1660-1666, December 2008.

Aberra, F.A., Stettler, N, Brensinger C, Lichtenstein G.R., Lewis, J.D: Risk for Active Tuberculosis in Inflammatory Bowel Disease Patients. Clinical Gastroenterology and Hepatology 5(9): 1070-5, September 2007.

Aberra FN, Lichtenstein GR: Infliximab in Ulcerative Colitis. Gastroenterology Clinics of North America 35(4): 821-836, December 2006.

Aberra, F: To be or not to be with infliximab during pregnancy? Inflammatory Bowel Diseases 12(1): 76-78, January 2006.

Aberra, F.A. , Brensinger, C. M., Bilker, W.B., Lichtenstein, G.R., Lewis, J.D: Antibiotic Use and the Risk of Flare of Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 3(5): 459-465, May 2005.

Aberra, F.A., Lewis, J.D., Haas, D, Rombeau J.L., Osborne, B, Lichtenstein, G.R: Preoperative Use of Azathioprine, 6-Mercaptopurine, or Corticosteroids and Risk for Postoperative Infectious Complications in Inflammatory Bowel Disease Patients Having Elective Bowel Surgery. Gastroenterology 125(2): 320-327, August 2003.

back to top
Last updated: 06/30/2020
The Trustees of the University of Pennsylvania